| http://www.w3.org/ns/prov#value | - In 2001, he was appointed head of the new Department of Experimental Medicine, which was created to explore new technologies such as pharmacogenomics in exploratory clinical trials, to work closely with FDA on clinical pharmacogenomics, and to bridge Discovery and Development with the creation of new biomarkers.
|
